Premium
Adoptive immunochemotherapy of a transplantable AKR leukemia (K36)
Author(s) -
Putman Donald L.,
Kind Phyllis D.,
Goldin Abraham,
Kende Meir
Publication year - 1978
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.2910210215
Subject(s) - leukemia , cancer research , biology , medicine , immunology
Adoptive immunotherapy of a transplantable AKR leukemia (K36) was carried out as an adjunct to cytoxan chemotherapy using normal allogeneic H‐2‐incompatible spleen cells as well as sensitized H‐2‐matched allogeneic spleen cells. A significant therapeutic effect was obtained with cytoxan and allogeneic C57BL/6 splenocytes, demonstrating the potential use of the graft‐versus‐host reaction. Utilizing specific adoptive immunochemotherapy, a maximum effect was found with splenocytes from allogeneic but H‐2‐compatible CBA/J mice immunized against an allogeneic Gross‐virus‐induced lymphoma (EoG2). This therapeutic effect was most likely the result of prior sensitization of donor lymphocytes to common virus‐associated tumor antigens.